S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCI Pharmtech Inc
Operating Expenses Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Operating Expenses
-NT$202.1m
CAGR 3-Years
-17%
CAGR 5-Years
3%
CAGR 10-Years
1%
Y
YungShin Global Holding Corp
TWSE:3705
Operating Expenses
-NT$2.1B
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
-2%
Formosa Laboratories Inc
TWSE:4746
Operating Expenses
-NT$1.3B
CAGR 3-Years
-10%
CAGR 5-Years
-10%
CAGR 10-Years
-12%
ScinoPharm Taiwan Ltd
TWSE:1789
Operating Expenses
-NT$891.2m
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
3%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Operating Expenses
-NT$4.7B
CAGR 3-Years
-13%
CAGR 5-Years
-10%
CAGR 10-Years
-15%
Standard Chem & Pharm Co Ltd
TWSE:1720
Operating Expenses
-NT$1.6B
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
-4%

See Also

What is SCI Pharmtech Inc's Operating Expenses?
Operating Expenses
-202.1m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Operating Expenses amounts to -202.1m TWD.

What is SCI Pharmtech Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
1%

Over the last year, the Operating Expenses growth was -13%. The average annual Operating Expenses growth rates for SCI Pharmtech Inc have been -17% over the past three years , 3% over the past five years , and 1% over the past ten years .

Back to Top